NCT06624085
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06624085
Title A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center RECRUITING La Jolla California 92093 United States Details
Saddleback Memorial Medical Center RECRUITING Laguna Hills California 92653 United States Details
University of California Los Angeles (UCLA) - Cancer Care - Santa Monica RECRUITING Santa Monica California 90404-2023 United States Details
Georgetown University RECRUITING Washington D.C. District of Columbia 20007 United States Details
AdventHealth Cancer Institute RECRUITING Orlando Florida 32804 United States Details
Winship Cancer Institute of Emory University RECRUITING Atlanta Georgia 30329 United States Details
University of Illinois Cancer Center RECRUITING Chicago Illinois 60612 United States Details
Kansas City VA Medical Center RECRUITING Kansas City Kansas 64128 United States Details
Walter Reed National Military Medical Center RECRUITING Bethesda Maryland 20814 United States Details
Christus Health - Christus St. Vincent Regional Medical Center RECRUITING Santa Fe New Mexico 87505 United States Details
Thomas Jefferson University RECRUITING Philadelphia Pennsylvania 19107 United States Details
Renovatio Clinical - El Paso RECRUITING El Paso Texas 79915 United States Details
Baylor College of Medicine RECRUITING Houston Texas 77030 United States Details
Renovatio Clinical RECRUITING The Woodlands Texas 77380 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field